This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Montero, A.
Right arrow Articles by Gudiol, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Montero, A.
Right arrow Articles by Gudiol, F.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, June 2002, p. 1946-1952, Vol. 46, No. 6
0066-4804/02/$04.00+0     DOI: 10.1128/AAC.46.6.1946-1952.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Efficacy of Colistin versus ß-Lactams, Aminoglycosides, and Rifampin as Monotherapy in a Mouse Model of Pneumonia Caused by Multiresistant Acinetobacter baumannii

A. Montero,1* J. Ariza,1 X. Corbella,1 A. Doménech,1 C. Cabellos,1 J. Ayats,2 F. Tubau,2 C. Ardanuy,2,{dagger} and F. Gudiol1

Laboratory of Experimental Infection, Infectious Disease Service,1 Microbiology Department, Hospital de Bellvitge, University of Barcelona, 08907 L'Hospitalet de Llobregat, Barcelona, Spain2

Received 3 December 2001/ Returned for modification 2 January 2002/ Accepted 7 March 2002

The treatment of life-threatening infections due to carbapenem-resistant Acinetobacter baumannii has become a serious challenge for physicians worldwide. Often, only colistin shows in general good in vitro activity against these carbapenem-resistant strains, but its antibacterial efficacy in comparison with the antibiotics most used in clinical practice is not well known. We studied the efficacy of colistin versus those of imipenem, sulbactam, tobramycin, and rifampin in an experimental pneumonia model with immunocompetent mice. We used three strains of A. baumannii corresponding to the main clones (A, D, and E) involved in the outbreaks of our hospital, with different grades of resistance to imipenem (imipenem MICs of 1, 8, and 512 µg/ml, respectively) and to the other antibiotics. The MIC of colistin was 0.5 µg/ml for the three strains. Reduction of log10 CFU/g in lung bacterial counts, clearance of bacteremia, and survival versus results with controls were used as parameters of efficacy. Imipenem and sulbactam ({Delta}lung counts: -5.38 and -4.64 log10 CFU/ml) showed the highest level of bactericidal efficacy in infections by susceptible and even intermediate strains. Tobramycin and rifampin (-4.16 and -5.15 log10 CFU/ml) provided good results against intermediate or moderately resistant strains, in agreement with killing curves and pharmacodynamics. On the contrary, colistin showed the weakest antibacterial effect among the antibiotics tested, both in killing curves and in the in vivo model (-2.39 log10 CFU/ml; P < 0.05). We conclude that colistin did not appear as a good option for treatment of patients with pneumonia due to carbapenem-resistant A. baumannii strains. Other alternatives, including combinations with rifampin, may offer better therapeutic profiles and thus should be studied.

* Corresponding author. Mailing address: N S Desamparados, 68 Ent. 1a, 08903 L'Hospitalet de Llobregat, Barcelona, Spain. Phone: 34 93 260 7625. Fax: 34 93 260 7637. E-mail: amontero{at}bell.ub.es.

{dagger} Present address: Hospital Universitari Joan XXIII, 43007 Tarragona, Spain.

Antimicrobial Agents and Chemotherapy, June 2002, p. 1946-1952, Vol. 46, No. 6
0066-4804/02/$04.00+0     DOI: 10.1128/AAC.46.6.1946-1952.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Aoki, N., Tateda, K., Kikuchi, Y., Kimura, S., Miyazaki, C., Ishii, Y., Tanabe, Y., Gejyo, F., Yamaguchi, K. (2009). Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa. J Antimicrob Chemother 63: 534-542 [Abstract] [Full Text]  
  • Sarig, H., Rotem, S., Ziserman, L., Danino, D., Mor, A. (2008). Impact of Self-Assembly Properties on Antibacterial Activity of Short Acyl-Lysine Oligomers. Antimicrob. Agents Chemother. 52: 4308-4314 [Abstract] [Full Text]  
  • Landman, D., Georgescu, C., Martin, D. A., Quale, J. (2008). Polymyxins Revisited. Clin. Microbiol. Rev. 21: 449-465 [Abstract] [Full Text]  
  • Peleg, A. Y., Seifert, H., Paterson, D. L. (2008). Acinetobacter baumannii: Emergence of a Successful Pathogen. Clin. Microbiol. Rev. 21: 538-582 [Abstract] [Full Text]  
  • Beceiro, A., Fernandez-Cuenca, F., Ribera, A., Martinez-Martinez, L., Pascual, A., Vila, J., Rodriguez-Bano, J., Cisneros, J. M., Pachon, J., Bou, G., on behalf of the Spanish Group for Nosocomial Infe, (2008). False extended-spectrum {beta}-lactamase detection in Acinetobacter spp. due to intrinsic susceptibility to clavulanic acid. J Antimicrob Chemother 61: 301-308 [Abstract] [Full Text]  
  • Perez, F., Hujer, A. M., Hujer, K. M., Decker, B. K., Rather, P. N., Bonomo, R. A. (2007). Global Challenge of Multidrug-Resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 51: 3471-3484 [Full Text]  
  • Rios, F. G., Luna, C. M., Maskin, B., Valiente, A. Saenz., Lloria, M., Gando, S., Sosa, C., Baquero, S., Llerena, C., Petrati, C., Apezteguia, C. (2007). Ventilator-associated pneumonia due to colistin susceptible-only microorganisms. Eur Respir J 30: 307-313 [Abstract] [Full Text]  
  • Saballs, M., Pujol, M., Tubau, F., Pena, C., Montero, A., Dominguez, M. A., Gudiol, F., Ariza, J. (2006). Rifampicin/imipenem combination in the treatment of carbapenem-resistant Acinetobacter baumannii infections. J Antimicrob Chemother 58: 697-700 [Abstract] [Full Text]  
  • Rodriguez-Hernandez, M. J., Saugar, J., Docobo-Perez, F., de la Torre, B. G., Pachon-Ibanez, M. E., Garcia-Curiel, A., Fernandez-Cuenca, F., Andreu, D., Rivas, L., Pachon, J. (2006). Studies on the antimicrobial activity of cecropin A-melittin hybrid peptides in colistin-resistant clinical isolates of Acinetobacter baumannii. J Antimicrob Chemother 58: 95-100 [Abstract] [Full Text]  
  • Yu, J., Wu, J., Francis, K. P., Purchio, T. F., Kadurugamuwa, J. L. (2005). Monitoring in vivo fitness of rifampicin-resistant Staphylococcus aureus mutants in a mouse biofilm infection model. J Antimicrob Chemother 55: 528-534 [Abstract] [Full Text]  
  • Montero, A., Ariza, J., Corbella, X., Domenech, A., Cabellos, C., Ayats, J., Tubau, F., Borraz, C., Gudiol, F. (2004). Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model. J Antimicrob Chemother 54: 1085-1091 [Abstract] [Full Text]  
  • Jain, R., Danziger, L. H (2004). Multidrug-Resistant Acinetobacter Infections: An Emerging Challenge to Clinicians. The Annals of Pharmacotherapy 38: 1449-1459 [Abstract] [Full Text]  
  • Kadurugamuwa, J. L., Sin, L. V., Yu, J., Francis, K. P., Kimura, R., Purchio, T., Contag, P. R. (2003). Rapid Direct Method for Monitoring Antibiotics in a Mouse Model of Bacterial Biofilm Infection. Antimicrob. Agents Chemother. 47: 3130-3137 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»